Risk factors for type 2 diabetes: Lessons learned from Japanese Americans in Seattle

Journal of Diabetes Investigation

Volumn 3, Issue 3, 2012, Pages 212-224

  Fujimoto, Wilfred Y ^a   Boyko, Edward J ^a,c   Hayashi, Tomoshige ^a,c   Kahn, Steven E ^a   Leonetti, Donna L ^a   McNeely, Marguerite J ^a   Shuman, William P ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Japanese Americans; Lifestyle; Obesity

Indexed keywords

ANTIDIABETIC AGENT; C PEPTIDE;

ANTHROPOMETRY; ASIAN AMERICAN; BODY FAT DISTRIBUTION; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; DISEASE SEVERITY; FEEDING BEHAVIOR; GENETIC SUSCEPTIBILITY; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MEDICAL SOCIETY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PILOT STUDY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; RISK FACTOR; SKINFOLD THICKNESS; UNITED STATES;

EID: 84861993148     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/j.2040-1124.2012.00195.x     Document Type: Review

References (92)

1. Sloan R. Ethnic distribution of diabetes mellitus in Hawaii. JAMA 1963; 183: 419-424.
2. Kagan A, Harris BR, Winkelstein W Jr, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California: demographic, physical, dietary and biochemical characteristics. J Chronic Dis 1974; 27: 345-364.
3. Kawate R, Yamakido M, Nishimoto Y, et al. Migrant studies?among the Japanese in Hiroshima and Hawaii. In: Waldhausl WK (ed). Diabetes 1979. Proc 10th Congr Int Diab Fed. Excerpta Med, Amsterdam, 1980; 526-531.
4. West K. Diabetes in American Indians and other native populations of the new world. Diabetes 1974; 23: 841-855.
5. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057.
6. Olefsky JM. Insulin resistance and insulin action: an in vitro and in vivo perspective. Diabetes 1981; 25: 1154-1165.
7. McNeely MJ, Boyko EJ. Type 2 diabetes mellitus prevalence in Asian Americans. Diabetes Care 2004; 27: 66-69.
8. Fujimoto WY, Hershon K, Kinyoun J, et al. Type II diabetes mellitus in Seattle and Tokyo. Tohoku J Exp Med 1983; 141(Suppl.): 133-139.
9. Fujimoto WY, Hershon KS, Kinyoun JL, et al. Maturity-onset diabetes in second generation Japanese American (Nisei) and Caucasian males in Seattle, Washington: a pilot study. In: Melish JS, Hanna J, Baba S (eds). Genetic Environmental Interaction in Diabetes Mellitus. Excerpta Medica, Amsterdam, 1982; 101-106.
10. U.S. Census Bureau. World Wide Web:.
11. Reeves TJ, Bennett CE. We the people: Asians in the United States. U.S. Census Bureau, 2004. World Wide Web:.
12. Leonetti DL, Newell-Morris L. Exogamy and change in the biosocial structure of a modern urban population. Am Anthropol 1982; 84: 19-36.
13. Fujimoto WY, Leonetti DL, Kinyoun JL, et al. Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese American men. Diabetes 1987; 36: 721-729.
14. Fujimoto WY, Leonetti DL, Bergstrom RW, et al. Glucose intolerance and diabetic complication among Japanese American women. Diabetes Res Clin Pract 1991; 13: 119-130.
15. Fujimoto WY, Bergstrom RW, Leonetti DL, et al. Metabolic and adipose risk factors for NIDDM and coronary disease in third-generation Japanese American men and women with impaired glucose tolerance. Diabetologia 1994; 37: 524-532.
16. Fujimoto WY. Diabetes in Asian Americans. In: Harris MI, Hamman RF (ed). Diabetes in America, Diabetes Data Compiled 1984. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, NIADDKD, Washington, D.C., 1985; X-1-X-12.
17. Fujimoto WY, Akanuma Y, Kanazawa Y, et al. Plasma insulin levels in Japanese and Japanese American men with type 2 diabetes may be related to the occurrence of cardiovascular disease. Diabetes Res Clin Pract 1989; 6: 121-127.
18. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4: 20-34.
19. Borkan GA, Gerzof SG, Robbins AH, et al. Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 1982; 36: 172-177.
20. Borkan GA, Hults DE, Gerzof SG, et al. Relationships between computed tomography tissue areas, thickness and total body composition. Ann Hum Biol 1983; 10: 537-546.
21. Tokunaga K, Matsuzawa Y, Ishikawa K, et al. A novel technique for the determination of body fat by computed tomography. Int J Obes 1983; 7: 437-445.
22. Shuman WP, Newell-Morris LL, Leonetti DL, et al. Abnormal body fat distribution detected by computed tomography in diabetic men. Invest Radiol 1986; 21: 483-487.
23. Newell-Morris LL, Treder RP, Shuman WP, et al. Fatness, fat distribution, and glucose tolerance in second-generation Japanese American (Nisei) men. Am J Clin Nutr 1989; 50: 9-18.
24. Tsunehara CH, Leonetti DL, Fujimoto WY. Diet of second-generation Japanese American men with and without non-insulin-dependent diabetes. Am J Clin Nutr 1990; 52: 731-738.
25. Leonetti DL, Tsunehara CH, Wahl PW, et al. Baseline dietary intake and physical activity of Japanese American men in relation to glucose tolerance at 5-year follow-up. Am J Hum Biol 1996; 8: 55-67.
26. Fujimoto WY, Leonetti DL, Newell-Morris L, et al. Relationship of absence or presence of a family history of diabetes to body weight and body fat distribution in type2 diabetes. Int J Obes 1991; 15: 111-120.
27. Freire RD, Cardoso MA, Shinzato AR, et al. Nutritional status of Japanese-Brazilian subjects: comparison across gender and generation. Br J Nutr 2003; 89: 705-712.
28. Ferreira SRG, Iunes M, Franco LJ, et al. Disturbances of glucose and lipid metabolism in first and second generation of Japanese Brazilians. Diabetes Res Clin Pract 1996; 34(Suppl.): S59-S63.
29. Gimeno SGA, Ferreira SRG, Cardoso MA, et al. Weight gain in adulthood and risk of developing glucose tolerance disturbance: a study of a Japanese-Brazilian population. J Epidemiol 2000; 10: 103-110.
30. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity. World Health Organization, Geneva, 1997.
31. Ferreira SRG, Lerario DDG, Gimeno SGA, et al. Obesity and central adiposity in Japanese immigrants: role of the western dietary pattern. J Epidemiol 2002; 12: 431-438.
32. Bergstrom RW, Leonetti DL, Newell-Morris LL, et al. Association of plasma triglyceride and C-peptide with coronary heart disease in Japanese American men with a high prevalence of glucose intolerance. Diabetologia 1990; 33: 489-496.
33. Boyko EJ, Leonetti DL, Bergstrom RW, et al. Visceral adiposity, fasting plasma insulin, and blood pressure in Japanese Americans. Diabetes Care 1995; 18: 174-181.
34. Hayashi T, Boyko EJ, Leonetti DL, et al. Visceral adiposity and the prevalence of hypertension in Japanese Americans. Circulation 2003; 108: 1718-1723.
35. Boyko EJ, Leonetti DL, Bergstrom RW, et al. Visceral adiposity, fasting plasma insulin, and lipid and lipoprotein levels in Japanese Americans. Int J Obes 1996; 20: 801-808.
36. Bergstrom RW, Newell-Morris LL, Leonetti DL, et al. Association of elevated fasting C-peptide and increased intra-abdominal fat distribution with development of NIDDM in Japanese American men. Diabetes 1990; 39: 104-111.
37. Fujimoto WY, Bergstrom RW, Boyko EJ, et al. Visceral adiposity and incident coronary heart disease in Japanese American men. The 10-year follow-up results of the Seattle Japanese American Community Diabetes Study. Diabetes Care 1999; 22: 1808-1812.
38. Hayashi T, Boyko EJ, Leonetti DL, et al. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med 2004; 140: 992-1000.
39. Hayashi T, Boyko EJ, Leonetti DL, et al. Visceral adiposity and the risk of impaired glucose tolerance. A prospective study among Japanese Americans. Diabetes Care 2003; 26: 650-655.
40. Boyko EJ, Fujimoto WY, Leonetti DL, et al. Visceral adiposity and risk of type2 diabetes. A prospective study among Japanese Americans. Diabetes Care 2000; 23: 465-471.
41. Tong J, Boyko EJ, Utzschneider KM, et al. Intra-abdominal fat accumulation predicts the development of the metabolic syndrome in non-diabetic Japanese Americans. Diabetologia 2007; 50: 1156-1160.
42. Hayashi T, Boyko EJ, McNeely MJ, et al. Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes 2008; 57: 1269-1275.
43. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
44. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 2004; 22: 1462-1470.
45. Boyko EJ, Leonetti DL, Bergstrom RW, et al. Fasting insulin level underestimates risk of non-insulin-dependent diabetes mellitus due to confounding by insulin secretion. Am J Epidemiol 1997; 145: 18-23.
46. Wareham NJ, Phillips DI, Byrne CD, et al. The 30minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 1995; 12: 931.
47. Lee CG, Fujimoto WY, Brunzell JD, et al. Intra-abdominal fat accumulation is greatest at younger ages in Japanese American adults. Diabetes Res Clin Pract 2010; 89: 58-64.
48. Chessler SD, Fujimoto WY, Shofer JB, et al. Increased plasma leptin levels are associated with fat accumulation in Japanese Americans. Diabetes 1998; 47: 239-243.
49. Tong J, Fujimoto WY, Kahn SE, et al. Insulin, C-peptide, and leptin concentrations predict increased visceral adiposity at 5- and 10-year follow-ups in nondiabetic Japanese Americans. Diabetes 2005; 54: 985-990.
50. McNeely MJ, Boyko EJ, Weigle DS, et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care 1999; 22: 65-70.
51. Seidell JC, Bjorntorp P, Sjostrom LS, et al. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990; 39: 897-901.
52. Tsai EC, Boyko EJ, Leonetti DL, et al. Low serum testosterone level as a predictor of increased visceral fat in Japanese American men. Int J Obes 2000; 24: 485-491.
53. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005; 112: 285-290.
54. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. Lancet 2005; 366: 1059-1062.
55. McNeely MJ, Boyko EJ, Shofer JB, et al. Standard definitions of overweight and central adiposity for determining diabetes risk in Japanese Americans. Am J Clin Nutr 2001; 74: 101-107.
56. Hayashi T, Boyko EJ, McNeely MJ, et al. Minimum waist and visceral fat values for identifying Japanese Americans at risk for the metabolic syndrome. Diabetes Care 2007; 30: 120-127.
57. Youden WJ. An index for rating diagnostic tests. Cancer 1950; 3: 32-35.
58. Perkins NJ, Schisterman EF. The inconsistency of "optimal" cut points obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 2006; 163: 670-675.
59. Steering Committee of the Western Pacific Region of the World Health Organization, the International Association for the Study of Obesity, and the International Obesity Task Force. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Health Communications Australia Pty Limited, Melbourne, 2000.
60. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
61. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981; 68: 1456-1467.
62. Porte D Jr. β-cells in type II diabetes mellitus. Diabetes 1991; 40: 166-180.
63. Utzschneider KM, Prigeon RL, Faulenbach MV, et al. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 2009; 32: 335-341.
64. Fujimoto WY, Bergstrom RW, Boyko EJ, et al. Type2 diabetes and the metabolic syndrome in Japanese Americans. Diabetes Res Clin Pract 2000; 50(Suppl. 2): S73-S76.
65. Sato Y, Komatsu M, Katakura M, et al. Diminution of early insulin response to glucose in subjects with normal but minimally elevated fasting plasma glucose. Evidence for early beta-cell dysfunction. Diabet Med 2001; 19: 566-571.
66. Kuroe A, Fukushima M, Usami M, et al. Impaired beta-cell function and insulin sensitivity in Japanese subjects with normal glucose tolerance. Diabetes Res Clin Pract 2003; 59: 71-77.
67. Yoshinaga H, Kosaka K. Heterogenous relationship of early insulin response and fasting insulin level with development of non-insulin-dependent diabetes mellitus in non-diabetic Japanese subjects with or without obesity. Diabetes Res Clin Pract 1999; 44: 129-136.
68. Jensen CC, Cnop M, Hull RL, et al. β-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes 2002; 51: 2170-2178.
69. Bergstrom RW, Wahl PW, Leonetti DL, et al. Association of fasting glucose levels with a delayed secretion of insulin after oral glucose in subjects with glucose intolerance. J Clin Endocrinol Metab 1990; 71: 1447-1453.
70. Chen KW, Boyko EJ, Bergstrom RW, et al. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. Diabetes Care 1995; 18: 747-753.
71. Kahn SE, Verchere CB, Andrikopoulos S, et al. Reduced amylin release is a characteristic of impaired glucose tolerance and type2 diabetes in Japanese Americans. Diabetes 1998; 47: 640-645.
72. Duckworth WC, Kitabchi AE, Heinemann M. Direct measurement of plasma proinsulin in normal and diabetic subjects. Am J Med 1972; 53: 418-427.
73. Fujimoto W, Bergstrom R, Leonetti D, et al. Fasting proinsulin and insulin: relationship to NIDDM and coronary heart disease (abstract). Diabetes 1992; 41(Suppl. 1): 124A.
74. Kahn SE, Leonetti DL, Prigeon RL, et al. Proinsulin as a marker for the development of NIDDM in Japanese American men. Diabetes 1995; 44: 173-179.
75. Kawamura T, Egusa G, Okubo M, et al. Association of beta3-adrenergic receptor gene polymorphism with insulin resistance in Japanese American men. Metabolism 1999; 48: 1367-1370.
76. Stone LM, Kahn SE, Fujimoto WY, et al. Association of the Trp64Arg β3-adrenergic receptor substitution with abnormal glucose tolerance but not body fat distribution or fasting insulin levels in Japanese Americans. Diabetes 1996; 45(Suppl. 2): 293A.
77. Deeb S, Fajas L, Nemoto M, et al. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284-287.
78. Nemoto M, Sasaki T, Deeb SS, et al. Differential effect of PPARγ2 variants in the development of type2 diabetes between native Japanese and Japanese Americans. Diabetes Res Clin Pract 2002; 57: 131-137.
79. Stone LM, Kahn SE, Deeb SS, et al. Glucokinase gene variations in Japanese Americans with a family history of NIDDM. Diabetes Care 1994; 12: 1480-1483.
80. Stone LM, Kahn SE, Fujimoto WY, et al. A variation at position -30 of the β-cell glucokinase gene promoter is associated with reduced β-cell function in middle-aged Japanese American men. Diabetes 1996; 45: 422-428.
81. Miyake K, Horikawa Y, Hara K, et al. Association of TCF7L2 polymorphisms with susceptibility to type2 diabetes in 4, 087 Japanese subjects. J Hum Genet 2008; 53: 174-180.
82. Yasuda K, Miyake K, Horikawa Y, et al. Variants in KCNQ1 are?associated with susceptibility to type2 diabetes mellitus. Nat Genet 2008; 40: 1092-1097.
83. Yokoi N, Kanamori M, Horikawa Y, et al. Association studies of variants in the genes involved in pancreatic beta-cell function in type2 diabetes in Japanese subjects. Diabetes 2006; 55: 2379-2386.
84. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-544.
85. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 343-350.
86. Diabetes Prevention Program Research Group. Reduction in the incidence of type2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
87. Liao D, Shofer JB, Boyko EJ, et al. Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese Americans with normal fasting glucose. Diabetes Care 2001; 24: 39-44.
88. McNeely MJ, Boyko EJ, Leonetti DL, et al. Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type2 diabetes risk in Japanese Americans. Diabetes Care 2003; 26: 758-763.
89. Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 2002; 136: 575-581.
90. Liao D, Asberry PJ, Shofer JB, et al. Improvement of BMI, body composition, and body fat distribution with lifestyle modification in Japanese Americans with impaired glucose tolerance. Diabetes Care 2002; 25: 1504-1510.
91. Carr DB, Utzschneider KM, Boyko EJ, et al. A reduced-fat diet and aerobic exercise in Japanese Americans with impaired glucose tolerance decreases intra-abdominal fat and improves insulin sensitivity but not β-cell function. Diabetes 2005; 54: 340-347.
92. Saito T, Watanabe M, Nishida J, et al. Lifestyle modification and prevention of type2 diabetes in overweight Japanese with impaired fasting glucose levels. Arch Intern Med 2011; 171: 1352-1360.